GLSI
Greenwich LifeSciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
GLSI vs peer average
69/100
GLSI vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CADL is the first available peer comparator.
Loose small-cap immunotherapy/oncology development peer with valuation driven mainly by clinical updates and capital access rather than current commercial cash flow.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GLSI
Greenwich LifeSciences
CADL
Candel Therapeutics
Grade
B
A
Momentum
83
94
Value
41
41
Sentiment
52
55
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CADL
GLSI / CADL
Grade Position
In line
GLSI vs. peer average (B vs. C)
69/100
Momentum
83
CADLValue
41
GLSISentiment
52
CADLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GLSI
CADL is the first peer returned for this comparison set.